STAT - Reporting from the frontiers of health and medicine

Health

Health

Biotech

Health ‘We’re going to keep going’: A new clinical trial for ALS gives patients hope
First Opinion We need new antimicrobials to prevent the next infectious disease crisis
Health Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Special Report Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Health Tech With Livongo’s arsenal of health devices, Teladoc is poised to move into remote monitoring

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change
Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Seres announces positive late-stage results for its microbe-based drug

Health

Health Tech

Health

Health

Health

By Ron Winslow

Health Tech

Health Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
Health Winter is coming: Why America’s window of opportunity to beat back Covid-19 is closing
Health ‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19
Health Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Health Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule
First Opinion We need new antimicrobials to prevent the next infectious disease crisis
Health The Covid-19 Tracker
Health Covid-19 infections leave an impact on the heart, raising concerns about lasting damage